Taysha Gene Therapies, Inc. (TSHA) Total liabilities 2022–2025
Taysha Gene Therapies, Inc. (TSHA) total liabilities at each fiscal year-end, per SEC filings.
$96.4MFY2025 · since FY2022: $125.3M → $96.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $96.4M | +8.5% |
| FY2024 | $88.8M | -9.2% |
| FY2023 | $97.8M | -22.0% |
| FY2022 | $125.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice